Villa Saroli, Viale Stefano Franscini, 9
PO BOX 5269 - CH-6901 Lugano, Switzerland
T +41 (0)91 921 11 54 | E
Associated to logo USI
Loading Events
  • This event has passed.

13th International AMD and Retina Congress


Organisers & Contacts

ESASO Organising Committee

President of the ESASO Foundation Giuseppe Guarnaccia, Italy
Vice President of the ESASO Foundation Board Borja Corcostegui, Spain
Member of the ESASO Foundation Board Francesco Bandello, Italy

Scientific Committee

Chairman Francesco Bandello, Italy
Co-Chairs Neil M. Bressler, USA
Marie Hickey Dwyer, Ireland
Coordinators Maurizio Battaglia-Parodi, Italy
Bruno Falcomatà, Italy

ESASO Congress Contacts

ESASO / ORGANISER c/o Università della Svizzera italiana
Via Lambertenghi 10 A
6904 Lugano, Switzerland
General Manager ESASO Gabriella Skala, Switzerland
Tel. +41 76 300 9000
Scientific Committee Coordinator Bruno Falcomatà
Tel. +39 (333) 31 35 566
Maurizio Battaglia-Parodi
Tel. +39 (340) 855 9739
Scientific Secretariat Shetal Gudka, Helen Cox
Tel. +44 208 326 3121
Logistics and Travel Management Luisa Marques, Isabel Oliveira
Tel. + 351 214 159 900

Scientific Programme

25- 26 October 2013, Dublin, Ireland

The Scientific Committee have developed an engaging scientific programme. Internationally renowned retinal specialists from all continents will present latest news from their fields of research and clinical practice.

You can look forward to:

Clinical presentations:
– 26 plenary presentations
– 6 panel based discussions
– 17 case study presentations
– 2 ESASO Style Debates and 3 ESASO Master Classes
(Sessions concurrent: Delegates to attend one session)

Rewarding achievement:
– Poster exhibition and presentation
– 4th ESASO Graduation Ceremony
– XOVA Award


Scientific Committee

Chair: Francesco Bandello, ITALY
Co-chairs: Neil M. Bressler, USA; Marie Hickey-Dwyer IRELAND


Scientific Committee Co-ordinators

Bruno Falcomata, ITALY
Maurizio Battaglia-Parodi, ITALY

E-Congress 2013

Friday, 25th October

Opening Ceremony
Welcome to Dublin
Francesco Bandello, Italy
Borja Corcóstegui, Spain
Giuseppe Guarnaccia, Italy
Marie Hickey-Dwyer, Ireland
The Global Challenge of Visual Impairment and Blindness
Chairs: Marco Zarbin, USA
Francesco Bandello, Italy
Global burden of visual impairment and blindness Rupert Bourne, UK
eXcellence in Ophthalmology Vision Award (XOVA) Winner to be announced
Low vision rehabilitation: Improving the patient outlook Gary Rubin, UK
Practical applications of stems cells and retinal transplantation Marco Zarbin, USA
Utilizing gene therapy and artificial vision Deniz Dalkara, France
Clinical Management of Diabetic Macular Edema and Diabetic Retinopathy
Chairs: Susan Bressler, USA
Anat Loewenstein, Israel
PDR: Beyond PRP Neil Bressler, USA
Practical management of DME: Selecting the appropriate therapy Francesco Bandello, Italy
Keypad case presentations Sobha Sivaprasad, UK
Paolo Lanzetta, Italy
Victor Chong, UK
Rafael Navarro, Spain
Panel discussion All
The Long-Term Management of AMD: Efficacy, Safety and Economic Considerations
Chairs: Paul Mitchell, Australia
Gabriel Coscas, France
Long-term vision outcomes with anti-VEGF Paul Mitchell, Australia
Are we under-treating our patients in the long term? Frank Holz, Germany
Examining the impact of switching from anti-VEGF therapy Paolo Lanzetta, Italy
Long-term safety and costs: A closer look Susan Bressler, USA
Keypad case presentations Sobha Sivaprasad, UK
Jean-François Korobelnik, France
Jordi Monés, Spain
Rafael Navarro, Spain
Panel discussion All
Poster Awards Presented by the Chair
Partnering to Resolve Unmet Medical Needs in Ophthalmology:
Novartis and Alcon R&D Approach
Sabri Markabi, USA
Dirk Sauer, Switzerland
Anti-VEGF Therapies Head-to-Head
Chairs: Alain Gaudric, France
Neil Bressler, USA
Bevacizumab versus ranibizumab comparative studies Usha Chakravarthy, Ireland
Ranibizumab versus aflibercept comparative studies Jean-François Korobelnik, France
Putting the patient at the center: Patient-reported outcomes and blindness Paul Mitchell, Australia
The development of geographic atrophy following anti-VEGF therapies Noemi Lois, UK
The treatment of RAP Adrian Koh, Singapore
Optimizing the treatment of PCV Nagahisa Yoshimura, Japan
Panel discussion All
Making the most of retinal therapies: Recent developments
Chairs: Susan Bressler, USA
Anselm Kampik, Germany
RADIANCE study results: Patients with CNV secondary to PM Francesco Bandello, Italy
Moving beyond anti-VEGF therapy: What next for geographic atrophy? Frank Holz, Germany
New drug treatments for wet AMD beyond anti-VEGFs Marco Zarbin, USA
The role of dietary supplements: AREDS2 Susan Bressler, USA
Radiation therapy with anti-VEGF: Strength in unity? Usha Chakravarthy, Ireland
Summary and Close Francesco Bandello, Italy

Saturday, 26th October

ESASO Graduation Ceremony
ESASO Fellowship Programme
Disorders of the Vitreo-Macular Interface
Chairs: Stanley Chang, USA
Borja Corcóstegui, Spain
A new classification system for VMT and macular hole Marc de Smet, Switzerland
New insights into ocriplasmin therapy Albert Augustin, Germany
Postoperative assessment of vitreoretinal interface disorders Stanley Chang, USA
Keypad case presentations Anselm Kampik, Germany
Antonio Capone, USA
Borja Corcóstegui, Spain
José García-Arumí, Spain
Panel discussion All
Best practice in RVO
Chairs: Alain Gaudric, France
José Cunha-Vaz, Portugal
ME in RVO: The appropriate use of steroids and anti-VEGF agents Anat Loewenstein, Israel
Clinical management of non-perfused RVO and ME: The role of anti-VEGF therapy
and scatter photocoagulation
Anselm Kampik, Germany
Keypad case presentations Emin Özmert, Turkey
Paolo Lanzetta, Italy
José Cunha-Vaz, Portugal
Alain Gaudric, France
Panel discussion All
Close of Meeting Francesco Bandello, Italy


The ‘13th International AMD and Retina Congress’ has been accredited by The Irish College of
Ophthalmologists and has been designated 8 External and 1 Internal credit points

Congress Information

Congress Venue

The Convention Centre Dublin

Welcome to The Convention Centre Dublin (The CCD), Ireland’s first purpose-built convention centre, located in Spencer Dock
in the heart of Dublin city.

Developed by Treasury Holdings, as part of a Public Private Partnership with the Office of Public Works (OPW), the CCD is the first state-owned, public-access building to be constructed since the foundation of the Irish State.Designed by Pritzker award-winning Irish-born architect Kevin Roche, the CCD has quickly become a landmark building. Its stunning design includes a unique glass-fronted atrium running the full height of the building, which gives visitors panoramic views of the river Liffey, Dublin city centre and the Wicklow mountains.The CCD was designed around the delegate experience and offers 22 multi-functional, flexible rooms suitable for meetings, conferences and exhibitions of all shapes and sizes – from small corporate meetings to international congresses. The entire venue is finished to the highest specifications and incorporates the latest technology throughout.

Congress Details

Badges for participants Participants will receive individual name badges when checking in for the Congress. According to the ESASO guidelines, name badges must be worn at all times throughout the Congress and evening functions.
Congress Language and Translators The official Congress language is English. Please take note that simultaneous translation may be provided at the request of respective countries, but will otherwise not be provided.
Food and Refreshments Food and refreshments are not included in the registration fee outside the congress times with the exception of the social events.
Insurance(s) The Organisers are not responsible for individual medical, travel or personal insurances. Delegates are advised to cover themselves with their own personal insurances.
Registration Desk – Opening Hours Official Congress Hotels:

  • To be informed
Smoking policy Smoking is strictly prohibited during all meetings, sessions and in the meeting rooms and halls at all times.


(eXcellence in Ophthalmology Vision Award)

Each year, three or more projects are awarded funding, in the form of a grant, to medical specialists who have devised non-profit, sustainable initiatives that are expected to have a significant positive impact on unmet needs in the field of ophthalmology and optometry. Winning initiatives are selected by the XOVA committee, which comprises over 30 esteemed international experts in eye health.

XOVA welcomes proposed initiatives from around the world, and XOVA 2013 is currently open for applications until 31 July 2013. For more information on the XOVA programme, including details on past XOVA winners and how to apply for the award, please visit the XOVA website at

The 13th International AMD and Retina Congress is proud to host the XOVA award ceremony, which will be taking place at the Congress Centre, Dublin, Ireland, over 25 and 26 October 2013.

XOVA is fully sponsored by Novartis Pharma and Alcon, and led by medical specialists in the field of eye care.

Grant Givers

This congress is supported by an unrestricted educational grant from:

Media Coverage


International meeting provides update on retinal disease therapy – CLICK HERE TO READ

Irish Medical Independent

Setting our sights on an end to vision impairing illnesses – CLICK HERE TO READ

Irish Medical Independent – Online Coverage

13th International AMD & Retina Congress, Dublin 2013 – CLICK HERE TO READ

Irish Medical News

Giving sight a fighting chance – CLICK HERE TO READ

Irish Medical Times – Online Coverage

Eye services ‘at bursting capacity’ – CLICK HERE TO READ
Breaking news: More than 1,100 eye surgeons set for Dublin meeting – CLICK HERE TO READ

Irish Times Supplement – Online Coverage

Experts now seeing advances on treatment of preventable blindness – CLICK HERE TO READ
The Irish Times currently has a readership of 321,000 daily

Event Tags


October 24, 2013


October 26, 2013


Dublin, Ireland

Share this event